Quality over Quantity: Comparison of Pathogenic CFTR Variants Across 10 Targeted Kit Panels Reveals Gaps and Opportunities for More Comprehensive Cystic Fibrosis Carrier Screening (ASHG 2020)

Quality over Quantity: Comparison of Pathogenic CFTR Variants Across 10 Targeted Kit Panels Reveals Gaps and Opportunities for More Comprehensive Cystic Fibrosis Carrier Screening (ASHG 2020)

Content of the AmplideX PCR/CE CFTR Kit panel has been updated since this webinar was recorded. Comparison of pathogenic CFTR variants across 10 targeted kit panels reveals gaps and opportunities for more comprehensive cystic fibrosis carrier screening.

Back To
Top